Here are the issue highlights and Editor Picks for the August issue of JDD:
Clearance of psoriasis leads to greater uptake of cosmetic procedures in Increased Trend of Cosmetic Procedures in Patients With Psoriasis Who Attain 75% or Greater Improvement.
The Effect of Tildrakizumab on Cardiometabolic Two Phase 3 Trials (reSURFACE 1 and reSURFACE 2) examines the impact of IL-23 inhibition on cardiometabolic risk factors in patients with moderate to severe psoriasis.
Metformin demonstrates promising clinical response and favorable safety profile for treatment in Oral Metformin for Treating Dermatological Diseases: A Systematic Review.
Fixed Combination Cal/BD Foam for Beyond-Mild Psoriasis: A Possible Alternative to Systemic Medication demonstrated favorable outcomes in patients with greater-than-mild psoriasis severity
Safety and efficacy of treatment of chronic plaque psoriasis is assessed in Roflumilast Cream Improves Signs and Symptoms of Plaque Psoriasis: Results from a Phase 1/2a Randomized, Controlled Study.
A post-hoc analysis evaluates efficacy in Nail Psoriasis Does Not Affect Skin Response to Ixekizumab in Patients With Moderate-to-Severe Psoriasis.
Halobetasol Propionate Lotion 0.01% for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis in Male and Female Participants investigates safety and efficacy.
An understanding of treatment modalities for PIH is essential in Post-Inflammatory Hyperpigmentation: A Review of Treatment Strategies.
The application of moisturizers and cleansers may help protect the developing skin barrier in a Consensus about the Importance of Ceramide Containing Skincare for Normal and Sensitive Skin Conditions in Neonates and Infants
Once-Daily Polymeric Tazarotene 0.045% Lotion for Moderate-to-Severe Acne: Pooled Phase 3 Analysis by Sex explores a promising new acne treatment for males and females.
Treating Scalp Psoriasis With Calcipotriol/Betamethasone Dipropionate Combination Cutaneous Foam: Review of Phase 2 Data provides an insight into the effective treatment of scalp psoriasis with Cal/BD foam in adult and adolescent patients.
The Therapeutic Use of Antioxidants for Melasma summarizes therapeutic benefit of antioxidants for disorders of hyperpigmentation.
One-Year Pharmacovigilance Update of Brodalumab further supports the safety profile of brodalumab.
Topical Cannabinoids for the Management of Psoriasis Vulgaris: Report of a Case and Review of the Literature highlights the need for more research in this area.
It is important to understand the framework of sun-protective agents in order to increase protection against skin disorders mediated or impacted by ultraviolet radiation in The State of Sunscreens in the US: Caveat Emptor.
Topical nitrogen mustard is a possible treatment option in Cutaneous Langerhans Cell Histiocytosis Responsive to Topical Nitrogen Mustard.